Breaking News Instant updates and real-time market news.

WLH

William Lyon Homes

$17.11

-0.13 (-0.75%)

07:28
08/13/19
08/13
07:28
08/13/19
07:28

William Lyon Homes upgraded to Outperform on valuation at Wedbush

As previously reported, Wedbush analyst Jay McCanless upgraded William Lyon Homes to Outperform from Neutral and raised his price target on the shares to $21 from $20. The analyst believes the recent pullback in shares has "effectively discounted" the reduction in his 2019 EPS estimates following the Q2 results. Overall, he views the shares as undervalued at current levels.

WLH William Lyon Homes
$17.11

-0.13 (-0.75%)

09/20/18
WEDB
09/20/18
DOWNGRADE
Target $22
WEDB
Neutral
William Lyon Homes downgraded to Neutral from Outperform at Wedbush
Wedbush analyst Jay McCanless downgraded William Lyon Homes to Neutral from Outperform and cut his price target to $22 from $35. In a research note to investors, McCanless estimated the company's exposure to Seattle and California at just under 50% of the company's community count, and says both markets have exhibited a rapid slowdown in unit sales and in home price appreciation. He does not see a near-term positive catalyst to reverse either trend.
11/28/18
JPMS
11/28/18
NO CHANGE
JPMS
JPMorgan remains cautious on Homebuilders after new home sales miss
JPMorgan analyst Michael Rehaut remains cautious on Homebuilding stocks after October new home sales fell 9%, below the Street's estimate of 4%. The analyst expects a "fairly tepid" recovery in housing starts to continue in 2019 and believes the current softness may last for a few more months. Further, he thinks builder fundamentals will moderate over the next two years. His Overweight-rated builders include Lennar (LEN), LGI Homes (LGIH) and William Lyon Homes (WLH). His Overweight-rated names in building products include Masonite (DOOR), Fortune Brands (FBHS) and Stanley Black & Decker (SWK).
12/19/18
ZELM
12/19/18
NO CHANGE
ZELM
William Lyon Homes removed from Top Idea Basket as a Buy at Zelman
08/13/19
WEDB
08/13/19
UPGRADE
WEDB
Outperform
William Lyon Homes upgraded to Outperform from Neutral at Wedbush

TODAY'S FREE FLY STORIES

CVGI

Commercial Vehicle Group

$7.18

0.08 (1.13%)

08:03
09/18/19
09/18
08:03
09/18/19
08:03
Hot Stocks
Commercial Vehicle Group acquires First Source Electronics for $44.75M »

Commercial Vehicle Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BE

Bloom Energy

$3.30

-0.89 (-21.24%)

08:03
09/18/19
09/18
08:03
09/18/19
08:03
Recommendations
Bloom Energy analyst commentary  »

Morgan Stanley stays…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SANW

S&W Seed

$2.33

-0.03 (-1.27%)

08:03
09/18/19
09/18
08:03
09/18/19
08:03
Earnings
S&W Seed reports Q4 non-GAAP EPS 50c, consensus $1.05 »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

AZO

AutoZone

$1,156.07

26.56 (2.35%)

08:03
09/18/19
09/18
08:03
09/18/19
08:03
Recommendations
AutoZone analyst commentary  »

AutoZone price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

ALL

Allstate

$107.94

1.56 (1.47%)

08:01
09/18/19
09/18
08:01
09/18/19
08:01
Conference/Events
Executives Club of Chicago to hold a breakfast meeting »

Breakfast Meeting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

  • 30

    Oct

CPRI

Capri Holdings

$31.68

-0.58 (-1.80%)

08:00
09/18/19
09/18
08:00
09/18/19
08:00
Recommendations
Capri Holdings analyst commentary  »

Capri Holdings price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NCR

NCR Corp.

$32.85

-0.26 (-0.79%)

07:59
09/18/19
09/18
07:59
09/18/19
07:59
Initiation
NCR Corp. initiated  »

NCR Corp. initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

ALNA

Allena Pharmaceuticals

$4.20

-0.035 (-0.83%)

07:55
09/18/19
09/18
07:55
09/18/19
07:55
Conference/Events
Allena Pharmaceuticals to hold a KOL breakfast meeting »

Management hosts a Key…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

  • 18

    Sep

  • 24

    Sep

AAPL

Apple

$220.77

0.89 (0.40%)

07:52
09/18/19
09/18
07:52
09/18/19
07:52
Recommendations
Apple analyst commentary  »

Apple iPhone launch could…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AVP

Avon Products

$4.79

0.09 (1.91%)

07:52
09/18/19
09/18
07:52
09/18/19
07:52
Hot Stocks
Avon Products announces launch of new skincare and make-up brand 'Distillery' »

Avon Products announces…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSM

TSMC

$45.15

0.55 (1.23%)

, AMD

AMD

$31.00

0.17 (0.55%)

07:51
09/18/19
09/18
07:51
09/18/19
07:51
Periodicals
TSMC extends production lead time for 7nm chip capacity, DIgiTimes reports »

TSMC (TSM) is extending…

TSM

TSMC

$45.15

0.55 (1.23%)

AMD

AMD

$31.00

0.17 (0.55%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

CBRL

Cracker Barrel

$167.79

2.84 (1.72%)

07:50
09/18/19
09/18
07:50
09/18/19
07:50
Recommendations
Cracker Barrel analyst commentary  »

Cracker Barrel price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

07:50
09/18/19
09/18
07:50
09/18/19
07:50
General news
U.S. MBA reported mortgage applications dipped -0.1% in the September 13 week »

U.S. MBA reported…

AKTS

Akoustis

$7.90

0.1 (1.28%)

07:48
09/18/19
09/18
07:48
09/18/19
07:48
Downgrade
Akoustis rating change  »

Northland downgrades…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

  • 12

    Nov

ACHV

Achieve Life Sciences

$2.23

-0.03 (-1.33%)

07:46
09/18/19
09/18
07:46
09/18/19
07:46
Conference/Events
Achieve Life Sciences to host investor day »

Investor day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 24

    Sep

CBWTF

Auxly Cannabis

$0.00

(0.00%)

07:45
09/18/19
09/18
07:45
09/18/19
07:45
Hot Stocks
Auxly Cannabis announces Canadian brokerage agreement with Kindred Partners »

Auxly Cannabis Group and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IOTS

Adesto Technologies

$10.63

-0.66 (-5.85%)

07:45
09/18/19
09/18
07:45
09/18/19
07:45
Initiation
Adesto Technologies initiated  »

Adesto Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ONCE

Spark Therapeutics

$104.41

-0.41 (-0.39%)

07:43
09/18/19
09/18
07:43
09/18/19
07:43
Hot Stocks
Spark Therapeutics, paralympic skier partner for genetic testing awareness »

Spark Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KLAC

KLA-Tencor

$152.55

1.38 (0.91%)

07:42
09/18/19
09/18
07:42
09/18/19
07:42
Recommendations
KLA-Tencor analyst commentary  »

KLA-Tencor price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VTVT

vTv Therapeutics

$1.73

-0.045 (-2.54%)

07:40
09/18/19
09/18
07:40
09/18/19
07:40
Hot Stocks
vTv Therapeutics presents additional data from Phase 2 Simplici-T1 study »

vTv Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Oct

07:40
09/18/19
09/18
07:40
09/18/19
07:40
General news
Treasury Market Outlook: yields extended declines overnight »

Treasury Market Outlook:…

GSK

GlaxoSmithKline

$41.10

0.49 (1.21%)

07:38
09/18/19
09/18
07:38
09/18/19
07:38
Conference/Events
FDA Non-Prescription Drugs Advisory Committee to hold a meeting »

The Committee discusses…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

  • 24

    Sep

  • 27

    Sep

  • 02

    Oct

OPGN

OpGen

$7.02

-0.07 (-0.99%)

07:37
09/18/19
09/18
07:37
09/18/19
07:37
Hot Stocks
OpGen says Curetis collaborator obtains option to license ARESdb »

OpGen reported an update…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BLK

BlackRock

$438.98

3.12 (0.72%)

, TROW

T. Rowe Price

$117.98

1.1 (0.94%)

07:37
09/18/19
09/18
07:37
09/18/19
07:37
Recommendations
BlackRock, T. Rowe Price analyst commentary  »

BlackRock's…

BLK

BlackRock

$438.98

3.12 (0.72%)

TROW

T. Rowe Price

$117.98

1.1 (0.94%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 26

    Sep

  • 27

    Oct

AXDX

Accelerate Diagnostics

$21.30

1.85 (9.51%)

07:36
09/18/19
09/18
07:36
09/18/19
07:36
Hot Stocks
Accelerate Diagnostics reports 'positive' results in three Pheno system studies »

Accelerate Diagnostics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.